ICON

ICLR · NASDAQ

$174.19+$6.05 (+3.60%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $168.14

Latest news

Press releaseOct 8, 8:00 AM ETBusiness Wire
ICON Schedules Third Quarter 2026 Earnings Conference Call
Press releaseAug 20, 8:30 AM ETBusiness Wire
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
Press releaseAug 6, 6:30 AM ETBusiness Wire
ICON Announces Pricing of USD 2.15 Billion Notes
Press releaseAug 4, 8:39 AM ETBusiness Wire
ICON Announces Private Offering of Notes
Press releaseJul 31, 4:15 PM ETBusiness Wire
ICON Announces Results of Annual General Meeting
Press releaseJul 29, 4:15 PM ETBusiness Wire
ICON Reports Second Quarter 2026 Results
Press releaseJul 28, 7:00 AM ETBusiness Wire
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
Press releaseJul 22, 6:00 AM ETBusiness Wire
ICON Schedules Second Quarter 2026 Earnings Conference Call
Press releaseJul 9, 4:51 PM ETGlobe Newswire
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law Firm
NewsJun 24, 9:25 AM ET
Icon Reports Q1 2026 Results: Full Earnings Call Transcript
NewsJun 23, 4:16 PM ET
Icon Q1 Adj. EPS $2.50 Beats $2.42 Estimate, Sales $2.034B Beat $1.999B Estimate
Press releaseJun 23, 4:15 PM ETBusiness Wire
ICON Reports First Quarter 2026 Results
NewsJun 23, 7:11 AM ET
Earnings Scheduled For June 23, 2026
NewsJun 22, 9:23 AM ETPiero Cingari
Earnings Volatility Watch: Micron And 9 Stocks Set For Big Moves This Week
NewsJun 22, 7:12 AM ET
ICON Picks Microsoft to Expand AI Use in Clinical Trials
Press releaseJun 22, 7:00 AM ETBusiness Wire
ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development
Press releaseJun 17, 4:15 PM ETBusiness Wire
ICON Schedules First Quarter 2026 Earnings Conference Call
NewsMay 28, 11:58 AM ET
Full Transcript: Icon Q4 2025 Earnings Call
Press releaseMay 27, 4:33 PM ETBusiness Wire
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
Press releaseMay 26, 4:05 PM ETBusiness Wire
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq
Press releaseMay 13, 8:00 AM ETBusiness Wire
ICON expands US early phase research capabilities with new clinic and outpatient centres
NewsApr 29, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseApr 29, 7:00 AM ETBusiness Wire
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results
Press releaseMar 24, 8:00 AM ETBusiness Wire
ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model
Press releaseMar 16, 11:02 AM ETGlobe Newswire
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Press releaseMar 5, 5:11 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR
Press releaseMar 3, 2:28 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICON plc – ICLR
Press releaseFeb 24, 6:00 PM ETBusiness Wire
ICLR INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ICON Public Limited Company
Press releaseFeb 24, 5:24 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR
Press releaseFeb 19, 8:04 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR
Press releaseFeb 19, 8:00 PM ETGlobe Newswire
ICLR SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Press releaseFeb 19, 7:45 PM ETBusiness Wire
ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm
NewsFeb 18, 10:10 AM ETVandana Singh
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer
NewsFeb 12, 12:34 PM ETAvi Kapoor
S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

ICON Schedules Third Quarter 2026 Earnings Conference Call

ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability

ICON Announces Pricing of USD 2.15 Billion Notes

ICON Announces Private Offering of Notes

ICON Announces Results of Annual General Meeting

ICON Reports Second Quarter 2026 Results

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

ICON Schedules Second Quarter 2026 Earnings Conference Call

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law Firm

Icon Reports Q1 2026 Results: Full Earnings Call Transcript

Icon Q1 Adj. EPS $2.50 Beats $2.42 Estimate, Sales $2.034B Beat $1.999B Estimate

ICON Reports First Quarter 2026 Results

Earnings Scheduled For June 23, 2026

Earnings Volatility Watch: Micron And 9 Stocks Set For Big Moves This Week

ICON Picks Microsoft to Expand AI Use in Clinical Trials

ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

ICON Schedules First Quarter 2026 Earnings Conference Call

Full Transcript: Icon Q4 2025 Earnings Call

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

ICON expands US early phase research capabilities with new clinic and outpatient centres

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICON plc – ICLR

ICLR INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ICON Public Limited Company

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

ICLR SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm

FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings